维普期刊资源整合服务平台（V6.5）

102篇 您的检索式：作者名="STADLER W M"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Phase Ⅱ trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck显示文摘	Cohen E E Rosen F Stadler W M	2003	J Clin Oncol2003，21，10：	1
2	Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site显示文摘	KAUFFMAN E C ROBINSON V L STADLER W M	2003	J Urol2003，169，：	1
3	Phase Ⅱ trial of ZD1839 in re- current or metastatic squamous cell carcinoma of the head and neck 显示文摘	Cohen E E Rosen F Stadler W M	2003	J Clin Oncol2003，21，10：	1
4	The role of systemic chem- otherapy in the treatment o{ kidney cancer显示文摘	George C M Stadler W M	2003	Cancer Treat Res2003，116，：	1
5	Metastasis Suppression:the Evolving Role of Metastasis Suppressor Genes for Regulating Cancer Cell Growth at the Secondary Site显示文摘	Kauffman E C Robinson V L Stadler W M	2003	J Urol2003，169，3：	1
6	Randomized Phase Ⅱ study of multiple does levels of CCI -779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinomas显示文摘	ATKINS M B HIDALGO M STADLER W M	2004	J Clin Oncol2004，22，：	1
7	Modeling of H+ and Cu2+ adsorption on calcium montmorillonite显示文摘	Stadler M Schindler P W		0，，3：	1
8	Chemical and isotopic indicators of point-source recharge to a karst aquifer,South Australia显示文摘	Herczeg A L Leaney F W J Stadler M F	1997	Journal of Hydrology1997，192，14：	1
9	Randomized phase Ⅱ study of multiple dose levels of CCI - 779, a novel mammalian target of rapamycin kinase inhibitor, in patients with ad- vanced refractory renal cell carcinoma显示文摘	ATKINS M B HIDALGO M STADLER W M	2004	J Clin Oncol2004，22，5：	1
10	A randomized phase Ⅱ trial of the matrix metalloproteinase inhibitor BMS-275291 in hormone-refractory prostate cancer patients with bone metastases显示文摘	LARA P N STADLER W M LONGMATE J	2006	Clin Cancer Res2006，12，5：	1
11	A phase II study of gemcitabine and capecitabine in metastatic renal cancer: a report of Cancer and Leukemia Group B pro- tocolg0008显示文摘	Stadler W M Halabi S Rini B	2006	Cancer2006，107，6：	1
12	Modeling of H^+ and Cu^2+ adsorption on calcium montmorillonite 显示文摘	Stadler M Schindler P W	1993	Clays and Clay Mineral1993，41，3：	1
13	Urinary nuclear matrix proteinas a marker for transitional cell carcinoma of the urinary tract显示文摘	Carpinito G A Stadler W M Briggman J V	1996	J Urol1996，156，4：	1
14	Kidney cancer显示文摘	Stadler W M	1998	Lancet1998，352，：	1
15	Phase lI ran- domized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic meta- static castrate-resistant prostate cancer显示文摘	Pili R Haggman M Stadler W M	2011	J Clin Oncol2011，29，32：	1
16	Proline-Catalyzed Mannich Reaction of Aldehydes with N-Boc-Imines 显示文摘	YANG J W STADLER M LIST B	2007	Angew Chem Int Ed2007，46，4：	1
17	Metastasis suppression:the evolving role of metastasis suppressor genes for regulating cancer cell growth at the se-condary site显示文摘	KAUF FMAN E C ROBINSON V L STADLER W M	2003	Urology2003，169，3：	1
18	Sorafenib in advanced clear-cell renal-cell carcinoma 显示文摘	Escudier B Eisen T Stadler W M	2007	N Engl J Med2007，356，2：	1
19	Sorafenib in advanced clear-cell renal-cell carcinoma 显示文摘	Escudier B Eisen T Stadler W M	2007	N Engl J Med2007，356，2：	1
20	Proline-catalysed Mannich reactions of acetaldehyde显示文摘	Yang J W Chandler C Stadler M	2008	Nature2008，452，7186：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示